Interestingly, micro-array data of the neuronal cells from AD patients revealed that at least 6 genes involved in the expression of CBPs are down-regulated [61], [62] suggesting that the down-regulation of these CBPs might be one of the basic causes of the increased pathogenicity in AD (see Table 3). The gene discussed is SRPX2; the disease is Alzheimer disease.